Tim Corson
Tim Corson
Professor, Indiana University School of Medicine
Verified email at - Homepage
Cited by
Cited by
Molecular understanding and modern application of traditional medicines: triumphs and trials
TW Corson, CM Crews
Cell 130 (5), 769-774, 2007
H Dimaras, TW Corson, D Cobrinik, A White, J Zhao, FL Munier, ...
Nature reviews Disease primers 1 (1), 1-23, 2015
Using expression profiling data to identify human microRNA targets
JC Huang, T Babak, TW Corson, G Chua, S Khan, BL Gallie, TR Hughes, ...
Nature methods 4 (12), 1045-1049, 2007
Small-molecule hydrophobic tagging–induced degradation of HaloTag fusion proteins
TK Neklesa, HS Tae, AR Schneekloth, MJ Stulberg, TW Corson, ...
Nature chemical biology 7 (8), 538-543, 2011
Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies
DE Rushlow, BM Mol, JY Kennett, S Yee, S Pajovic, BL Thériault, ...
The lancet oncology 14 (4), 327-334, 2013
Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma
H Dimaras, V Khetan, W Halliday, M Orlic, NL Prigoda, B Piovesan, ...
Human molecular genetics 17 (10), 1363-1372, 2008
One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma
TW Corson, BL Gallie
Genes, Chromosomes and Cancer 46 (7), 617-634, 2007
Global retinoblastoma presentation and analysis by national income level
ID Fabian, E Abdallah, SU Abdullahi, RA Abdulqader, SA Boubacar, ...
JAMA oncology 6 (5), 685-695, 2020
Design and applications of bifunctional small molecules: why two heads are better than one
TW Corson, N Aberle, CM Crews
ACS chemical biology 3 (11), 677-692, 2008
The genomic landscape of retinoblastoma: a review
BL Thériault, H Dimaras, BL Gallie, TW Corson
Clinical & experimental ophthalmology 42 (1), 33-52, 2014
Posttranslational protein knockdown coupled to receptor tyrosine kinase activation with phosphoPROTACs
J Hines, JD Gough, TW Corson, CM Crews
Proceedings of the National Academy of Sciences 110 (22), 8942-8947, 2013
KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers
TW Corson, A Huang, MS Tsao, BL Gallie
Oncogene 24 (30), 4741-4753, 2005
Retinoblastoma, the visible CNS tumor: a review
H Dimaras, TW Corson
Journal of neuroscience research 97 (1), 29-44, 2019
Small-molecule covalent modification of conserved cysteine leads to allosteric inhibition of the TEAD⋅ Yap protein-protein interaction
K Bum-Erdene, D Zhou, G Gonzalez-Gutierrez, MK Ghozayel, Y Si, D Xu, ...
Cell chemical biology 26 (3), 378-389. e13, 2019
KIF14 mRNA expression is a predictor of grade and outcome in breast cancer
TW Corson, BL Gallie
International journal of cancer 119 (5), 1088-1094, 2006
Primary cilia signaling mediates intraocular pressure sensation
N Luo, MD Conwell, X Chen, CI Kettenhofen, CJ Westlake, LB Cantor, ...
Proceedings of the National Academy of Sciences 111 (35), 12871-12876, 2014
KIF14 Messenger RNA Expression Is Independently Prognostic for Outcome in Lung Cancer
TW Corson, CQ Zhu, SK Lau, FA Shepherd, MS Tsao, BL Gallie
Clinical cancer research 13 (11), 3229-3234, 2007
Profiling genomic copy number changes in retinoblastoma beyond loss of RB1
E Bowles, TW Corson, J Bayani, JA Squire, N Wong, PBS Lai, BL Gallie
Genes, Chromosomes and Cancer 46 (2), 118-129, 2007
Synthesis and biological evaluation of novel homoisoflavonoids for retinal neovascularization
HD Basavarajappa, B Lee, H Lee, RS Sulaiman, H An, C Magaña, ...
Journal of Medicinal Chemistry 58 (12), 5015-5027, 2015
Natural product inhibitors of ocular angiogenesis
RS Sulaiman, HD Basavarajappa, TW Corson
Experimental eye research 129, 161-171, 2014
The system can't perform the operation now. Try again later.
Articles 1–20